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In order to heal cancer, chemotherapeutic treatments have been investigated over the last several decades. 1, 2) Conformation studies and synthesis of medium-sized heterocyclic compounds, which have been investigated as the scaffolds of many biologically interesting structures, have received more attention. [3] [4] [5] Recently, we studied the synthesis of 3-arylisoquinoline derivatives such as indeno [1,2-c] isoquinolines, 6, 7) isoindolo [2,1-b] isoquinolines, 8) benz[b]oxepines 9) and benzo-[c]phenanthridinones 10) as constrained structures through molecular modeling to find plausible antitumor agents. The diversely rigidified 3-arylisoquinoline analogs exhibited promising cytotoxicities and topoisomerase I inhibitory activities. 11) We also reported the convenient synthesis of protoberberines using ring-closing metathesis (RCM) as shown in Fig. 1 . 12) Seven-membered heterocyclic rings are considered attractive molecules due to the points of structural determination of natural products as well as their interesting pharmacological actions. [3] [4] [5] In this paper we applied RCM [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] for the formation of seven-membered benzo [3, 4] azepino [1,2-b] isoquinolinone 5, and the retrosynthetic pathway of benzo [3, 4] azepino [1,2-b] isoquinolinone 5 is depicted in Chart 1. The coupling reaction of toluamide 7 with benzonitrile 8 afforded the 3-arylisoquinolinone 6, which could be modified to diene 4 as a key intermediate for the RCM reaction.
The synthetic approach of using the RCM reaction to prepare the seven-membered ring was based on the synthesis of 3-arylisoquinolines 4 that contain olefins at the appropriate positions. To synthesize the 3-arylisoquinoline 6a, a coupling reaction between N,N-diethyl-o-toluamide 7a and benzonitrile 8a was performed (Chart 2). 10) Generally, the chemical yield of this reaction is low (33 to 49%) due to the unknown side product and it is quite dependent on the substitution pattern of aromatic rings of the starting materials. 10) As a part of our continuous research on natural alkaloids synthesis, including biological evaluation of 3-arylisoquinolines, the coupling reaction of o-toluamides with benzonitriles was utilized to provide the desired molecules. 27) Significant increases in the topoisomerase I inhibitory activities of these compounds were observed through conversion of flexible 3-aryl rings to rigid forms such as isoindolo [2,1-b] isoquinolinones, benz-[b]oxepines, 12-oxobenzo[c]phenanthridinones and indeno-[1,2-c]isoquinolines, and molecular docking studies were used to explain the potency of these compounds.
11) The above coupling reaction has advantages as a synthetic tool for the construction of 3-arylisoquinolines because it is easily adaptable to starting materials with diverse aromatic ring substitutions and it is a one-pot procedure for the construction of all essential carbon atoms in the desired molecules.
Next, the amide 6a was reacted with allyl bromide and K 2 CO 3 in N,N-dimethylformamide (DMF) to provide the Nallyl compound 9a in 67% yield without giving an O-allyl product. When we tried to get an alkyl group such as methyl or PMB, only N-alkylated compounds were obtained. Methoxymethyl (MOM) was removed from 9a with 10% HCl to afford the alcohol 10a, which was then reacted with PDC in CH 2 Cl 2 to furnish the aldehyde 11a in 99% yield. Wittig reactions of the aldehyde 11a with Ph 3 PCH 3 Br and nBuLi in tetrahydrofuran (THF) gave the desired olefin 4a in 79% yield. Finally, RCM reaction of 4a with 1st generation Grubbs catalyst in CH 2 Cl 2 furnished the desired cyclized product 5a in 66% yield. When we carried out this reaction using 2nd generation catalyst, the similar result was obtained. 4,5-Dimethoxy toluamides 7b and benzonitriles 8b also provided the corresponding coupling products 6b in 49% yield. The reactions for the preparation of 9b, 10b, 11b, 4b, and 5b were also conducted following similar procedures applied for 5a.
The structures of benzoazepinoisoquinolones were determined by 1D 1 H-, 13 C-NMR and 2D (Fig. 2) . HSQC cross peaks of H7a/C7 and H7b/C7 corroborated that the protons are attached to the same carbon C7 (Fig. 3) . Furthermore, (Fig. 4) . Difference in chemical shifts of geminal, methylene protons of azepine ring adjoined to naphthoquinone and of azocine ring bridging biphenyl group have also been reported. 28, 29) In addition, formation of azepine ring by RCM of olefin 4 was established by HMBC analysis (Fig. 5) . HMBC correlation peaks, H5/C7, H6/C4a and H7a,b/C5, clearly indicated that seven membered ring was formed by intramolecular olefin metathesis. In the similar manner, the spectral data of azepine derivatives 5b were in total agreement with the proposed structure.
In conclusion, cycloaddition reaction between toluamides 7a, b and benzonitriles 8a, b was utilized to prepare the 3-arylisoquinolines 6a, b, which retain the main template for the RCM reaction, to construct the seven-membered heterocyclic compounds, benzo [3, 4] azepino [1,2-b] isoquinolinones 5a, b. The conventional transformation of 3-arylisoquinolines 6a, b to dienes 4a, b was carried out and the subsequent RCM reaction furnished the desired benzo [3, 4] azepino [1,2-b] isoquinolinones 5a, b in 66% and 85% yield, respectively. We believe that the RCM reaction could be an efficient method for the preparation of heterocyclic medium-sized rings.
Experimental
Melting points were determined by the capillary method on an Electrothermal IA9200 digital melting point apparatus and were uncorrected.
1 H-NMR spectra were obtained at 300 or 500 MHz, using Varian 300 or Kjui 500-Inova 500 FT spectrometer at the Korea Basic Science Institute and were reported in ppm, downfield from the peak of the internal standard, tetramethylsilane. The data are reported as follows: chemical shift, number of protons, multiplicity (s: singlet, d: doublet, t: triplet, q: quartet, m: multiplet, b: broadened). 1 
H-
1 H COSY, HSQC and HMBC spectra were obtained using Kjui 500-Inova 500 FT spectrometer. IR spectra were recorded on a JASCO-FT IR spectrometer using CHCl 3 or KBr pellets. Mass spectra were obtained on JEOL JNS-DX 303 using the electron-impact (EI) method. Column chromatography was performed on Merck silica gel 60 (70-230 mesh). TLC was performed using plates coated with silica gel 60 F254 that were purchased from Merck.
3-(4-Benzyloxy-2-methoxymethoxymethyl-phenyl)-2H-isoquinolin-1-one (6a)
A solution of N,N-diethylbenzamide 7a (1.6 g, 8.0 mmol) and benzonitrile 8a (3.4 g, 12 mmol) in dry THF (20 ml) were added drop wise to a solution of n-butyllithium (5 ml of 2.5 M in hexane, 12.5 mmol) in THF (20 ml) at Ϫ70°C, and then the reaction mixture was stirred at the same temperature for 6 h. The reaction was quenched with water, extracted with ethyl acetate and dried over sodium sulfate. After removal of the solvent, the residue was purified by column chromatography with n-hexane-ethyl acetate 
6,7-Dimethoxy-3-(6-methoxymethoxymethylbenzo[1,3]dioxol-5-yl)-2H-isoquinolin-1-one (6b)
The procedure described for compound 6a was used with N,N-diethyl-4,5-dimethoxy-2-methylbenzamide 7b (1.51 g, 6 mmol) and benzonitrile 8b (11.66 g, 7.5 mmol) in the presence of n-BuLi (6 ml of 2.5 M in hexane, 15 mmol) to give compound 6b as bright yellow solid (1.2 g, 49% 
2-Allyl-3-(4-benzyloxy-2-methoxymethoxymethylphenyl)-2H-isoquinolin-1-one (9a)
To a solution of 3-arylisoquinoline 6a (1.0 g, 2.5 mmol) and K 2 CO 3 (1.05 g, 7.5 mmol) in DMF (20 ml) was added allyl bromide (600 mg, 5 mmol). The mixture was stirred at room temperature for 12 h, quenched with water, and extracted with ethyl acetate. The combined ethyl acetate extracts were washed with water and brine and dried over anhydrous sodium sulfate. After removing the solvent in vacuo, the residue was purified by column chromatography on silica gel with n-hexane-ethyl acetate (2 : 1) to give compound 9a as yellow oil (735 mg, 67%). IR (cm 5-yl)-2H-isoquinolin-1-one (9b) The procedure described for compound 9a was used with 3-arylisoquinoline 6b (373 mg, 0.93 mmol) and K 2 CO 3 (400 mg, 3 mmol) in DMF (20 ml) and allyl bromide (240 mg, 2 mmol) to give compound 9b as yellow oil (252 mg, 62% 
2-Allyl-3-(4-benzyloxy-2-hydroxymethylphenyl)-2H-isoquinolin-1-one (10a)
To a solution of compound 9a (700 mg, 0.84 mmol) in THF (15 ml) was added 10% HCl (10 ml), and the reaction was refluxed for 2 h. After cooling to room temperature, the reaction mixture was poured into water and extracted with ethyl acetate. The ethyl acetate extracts were washed with water and brine and dried over anhydrous sodium sulfate. After removal of the solvent in vacuo the residue was purified by column chromatography on silica gel with n-hexane-ethyl acetate (1 : 2) to produce the alcohol 10a as yellow oil (421 mg, 67%). IR (cm 
2-(2-Allyl-1-oxo-1,2-dihydroisoquinolin-3-yl)-5-benzyloxybenzaldehyde (11a)
To a solution of alcohol 10a (400 mg, 1.0 mmol) in methylene chloride (30 ml) was added PDC (760 mg, 2 mmol), and the mixture was stirred for 2 h at room temperature. The reaction mixture was filtered off and the filtrate was washed with CH 2 Cl 2 . The solvent was evaporated off, and the residue was purified by column chromatography on silica gel with nhexane-ethyl acetate (2 : 1) to afford the aldehyde 11a as a brown oil (390 mg, 99%). IR (cm 
2-Allyl-3-(4-benzyloxy-2-vinylphenyl)-2H-isoquinolin-1-one (4a)
To a solution of methyltriphenylphosphonium bromide (1.6 g, 4.5 mmol) in dry THF (30 ml) was added n-butyllithium (1.8 ml of 2.5 M in hexane, 4.5 mmol) at 0°C, and the solution was stirred at 0°C for 1 h. To this mixture was added the aldehyde 11a (350 mg, 0.9 mmol) in THF (10 ml); the resulting mixture was stirred at room temperature for 1 h, quenched with water, and extracted with ethyl acetate. The combined organic layers were washed with water and brine and dried over sodium sulfate. After removing the solvent, the residue was purified by column chromatography with n-hexane-ethyl acetate (3 : 1) to afford the olefin 4a as a brown oil (281 mg, 79%). 2-Allyl-6,7-dimethoxy-3-(6-vinylbenzo[1,3]dioxol-5-yl)-2H-isoquinolin-1-one (4b) The procedure described for compound 4a was used with the aldehyde 11b (88 mg, 0.224 mmol) and methyltriphenylphosphonium bromide (430 mg, 1.12 mmol) and n-butyllithium (0.5 ml of 2.5 M in hexane, 1.25 mmol) in dry THF (30 ml) to afford the olefin 4b as yellow oil (56 mg, 75% Dimethoxy-2,3-[1,3-dioxol])-7H-benzo[3,4]azepino[1,2-b] isoquinolin-9-one (5b) The procedure described for compound 5a was used with the olefin 4b (55 mg, 0.14 mmol) and 1st generation Grubbs catalyst (23 mg, 20%) in CH 2 Cl 2 (15 ml) to produce the azepine 5b as brown needles (43 mg, 85% 
